首页 | 本学科首页   官方微博 | 高级检索  
检索        


Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: Further evidence for a role in schizophrenia
Authors:Takahiro Shinkai  Vincenzo De Luca  Rudi Hwang  Daniel J Muller  Matthew Lanktree  Gwyneth Zai  Sajid Shaikh  Gregory Wong  Tricia Sicard  Natalia Potapova  Joseph Trakalo  Nicole King  Chima Matsumoto  Hiroko Hori  Albert H C Wong  Osamu Ohmori  Fabio Macciardi  Jun Nakamura  James L Kennedy
Institution:(1) Neurogenetics Section, Center for Addiction and Mental Health, Clarke Division, Department of Psychiatry, University of Toronto, M5T 1R8 Toronto, Ontario, Canada;(2) Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, 807-8555 Kitakyushu, Japan;(3) Health Management Department, Shimonoseki Shipyard & Machinery Works, Mitsubishi Heavy Industries, Ltd., 750-8505 Shimonoseki, Japan;(4) Department of Psychiatry, Charité University Medicine Berlin, Campus Charité Mitte, Berlin, Germany;(5) Nissan Technical Center Health Promotion Center, Nissan Motor Co., Ltd., 243-0192 Atsugi, Japan;(6) Wakato Hospital, Wakamatsu-ku, 808-0132 Kitakyushu, Japan
Abstract:A number of linkage studies have previously implicated the region of chromosome 13q34 in schizophrenia. Chumakov and colleagues (2002) identified a gene complex called G72 (now termed d-amino acid oxidase activator: DAOA)/G30 in this region and performed association analyses of the DAOA/G30 as well as the d-amino-acid oxidase (DAAO) gene with schizophrenia. DAAO oxidizes d-serine, a potent activator of the N-methyl-d-aspartate (NMDA) type glutamate receptor in the human brain whereas the DAOA protein is considered an activator of DAAO. The interaction of these two genes has thus been implicated in the NMDA receptor regulation pathway in schizophrenia. To date, several studies have shown a relatively consistent positive association between schizophrenia and DAOA/G30, but not with DAAO. The aim of our study was to further evaluate the contributions of these genes to the susceptibility to schizophrenia using two different sample sets. Our sample consisted of 168 matched case-control pairs as well as a family-based sample (n=113) for transmission disequilibrium test. Significant associations between the DAOA/G30 M-7 and M-18 polymorphisms and schizophrenia were observed in our case-control sample whereas no associations were observed for DAAO markers. We also observed significant or suggestive transmission disequilibrium for DAOA/G30 M-7, M-23, and M-24 to probands with schizophrenia in our family-based sample. Subsequent analysis of haplotypes made up of four DAOA/G30 markers, one marker selected from each of two linkage disequilibrium blocks that were observed in our sample as well as both ends (M-7 and M-25), were also associated with schizophrenia. Our data provide further evidence that the DAOA/G30 locus may play a role in the pathophysiology of schizophrenia. Although no direct link to genetic polymorphism in these genes and NMDA receptor function has been revealed, the present findings support previous reports implicating DAOA/G30 as susceptibility genes for schizophrenia. Further research is warranted to determine the functional variation underlying these findings and to relate this to the pathophysiology of schizophrenia.
Keywords:Association study  chromosome 12  chromosome 13            d-amino-acid oxidase" target="_blank">d-amino-acid oxidase  DAOA  G30  G72  genetics  polymorphism  Schizophrenia  transmission disequilibrium test
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号